Literature DB >> 14681225

Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover.

Rebecca Ley1, Katherine E Ewings, Kathryn Hadfield, Elizabeth Howes, Kathryn Balmanno, Simon J Cook.   

Abstract

Bim, a "BH3-only" protein, is expressed de novo following withdrawal of serum survival factors and promotes cell death. We have shown previously that activation of the ERK1/2 pathway promotes phosphorylation of Bim(EL), targeting it for degradation via the proteasome. However, the nature of the kinase responsible for Bim(EL) phosphorylation remained unclear. We now show that Bim(EL) is phosphorylated on at least three sites in response to activation of the ERK1/2 pathway. By using the peptidylprolyl isomerase, Pin1, as a probe for proline-directed phosphorylation, we show that ERK1/2-dependent phosphorylation of Bim(EL) occurs at (S/T)P motifs. ERK1/2 phosphorylates Bim(EL), but not Bim(S) or Bim(L), in vitro, and mutation of Ser(65) to alanine blocks the phosphorylation of Bim(EL) by ERK1/2 in vitro and in vivo and prevents the degradation of the protein following activation of the ERK1/2 pathway. We also find that ERK1/2, but not JNK, can physically associate with GST-Bim(EL), but not GST-Bim(L) or GST-Bim(S), in vitro. ERK1/2 also binds to full-length Bim(EL) in vivo, and we have localized a potential ERK1/2 "docking domain" lying within a 27-amino acid stretch of the Bim(EL) protein. Our findings provide new insights into the post-translational regulation of Bim(EL) and the role of the ERK1/2 pathway in cell survival signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14681225     DOI: 10.1074/jbc.M311578200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

Review 1.  Cytokine-mediated cell survival.

Authors:  Toshiya Inaba
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

2.  Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.

Authors:  C Clybouw; D Merino; T Nebl; F Masson; M Robati; L O'Reilly; A Hübner; R J Davis; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

3.  Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth.

Authors:  Yaxiong Tang; Xuesen Li; Zhongbo Liu; Anne R Simoneau; Jun Xie; Xiaolin Zi
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

4.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

5.  Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity.

Authors:  Hisashi Harada; Bonnie Quearry; Antonio Ruiz-Vela; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

6.  Pharmacological manipulation of Bcl-2 family members to control cell death.

Authors:  Anthony Letai
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

7.  Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.

Authors:  Mauricio J Reginato; Kenna R Mills; Esther B E Becker; Danielle K Lynch; Azad Bonni; Senthil K Muthuswamy; Joan S Brugge
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.

Authors:  Eun-Sun Choi; Sejun Oh; Boonsil Jang; Hyun-Ju Yu; Ji-Ae Shin; Nam-Pyo Cho; In-Hyoung Yang; Dong-Hoon Won; Hye-Jeong Kwon; Seong Doo Hong; Sung-Dae Cho
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

Review 9.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

Review 10.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.